Another Secondary Announced 2.17.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Neurocrine Biosciences Symbol: NBIX Price: Last trade $37.33 Trade Date: 2/19 Shares: 6 million Underwriter(s) J.P. Morgan, Deutsche Bank Securities Rating=Subscription[…]